Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001610618-25-000042
Filing Date
2025-04-25
Accepted
2025-04-25 16:18:13
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS cdtx10-k2024x12x31_ars.pdf ARS 7480210
  Complete submission text file 0001610618-25-000042.txt   10305395
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36912 | Film No.: 25874354
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)